Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Which HSG method hurts less and shows more? study puts three techniques to the test

NCT ID NCT07583758

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study looked at 251 women with infertility who had a hysterosalpingography (HSG) — an X-ray test that checks if the fallopian tubes are open. The researchers compared three different ways of doing the test: using a metal cannula, an active balloon, or a passive balloon. They measured how much pain each method caused and how well the images helped doctors see the tubes clearly. The goal was to find which technique is best for both patient comfort and accurate diagnosis.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Hysterosalpingography (X-ray dye test of the fallopian tubes)
What this could lead to
If one method proves clearly better, it could become the standard way to perform this infertility test, making it less painful and more reliable.
What could go wrong
This is a small, completed study comparing techniques already in use, so it won't lead to a new treatment or cure. The results may not apply to all clinics or patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

251 people

The number who actually took part.

Started

Jan 2020

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 50 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: \- Female patients with infertility Exclusion Criteria: * Male patients * Patients who are diagnosed with menopause * Patients who do not want to proceed with HSG for diagnosis purposes

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hysterosalpingography are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Istanbul Medipol University, Medipol Mega University Hospital

    Istanbul, 34214, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.